S 5203 United States Senate · 118th Congress

Maternal and Infant Syphilis Prevention Act

This bill (S 5203) requires the U.S. Health Secretary to issue guidance to state Medicaid and CHIP programs within one year of enactment. The guidance focuses on improving syphilis screening access for pregnant women, especially during the third trimester and at delivery, and providing education for medical staff and patients. It also directs states to adopt best practices for telehealth integration, multilingual resources, and treatment strategies to prevent congenital syphilis. The bill directly affects pregnant women, newborns, and state health programs administering Medicaid/CHIP services, aiming to reduce preventable congenital syphilis cases through standardized screening and care protocols.
Bill status in committee 1 of 4 stages cleared
Introduction
Sep 2024
Committee Review
Floor Vote
President
Introduced Sep 25, 2024 Last action Sep 25, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Sep 25, 2024
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Sep 25, 2024
Introduced
Introduced in Senate
upper
1 primary · 3 co-sponsors

Sponsors